Moderation log
Page 6 of 9.
-
Publishing an inconvenient result: a case study
Reverted an edit that removed a citation and kept the sentence it supported. That leaves an unsourced claim in a maintained document, which is worse than either the original or a clean deletion. R2.
-
Washout: how long is long enough, and for what purpose
Auto-closed after the configured interval with no reply. Nothing wrong with the topic; the platform closes quiet topics so that a two-year-old answer does not attract a new question underneath it. Anyone with a follow-up should open a new topic and link back.
-
Why most self-reports here are not experiments, and that is fine
Closed. The topic has been superseded by a maintained document that now covers the same ground with citations and a review date. The document links back here and this topic links forward. Neither is deleted.
-
Reporting a disappointing outcome, and why it belongs here
Closed under R15. The topic re-litigated a decision already answered in Meta, without new argument. The earlier answer is linked from the first post.
-
EU-wide position versus national implementation
Unlisted at the request of two clinicians in the topic, who considered the first post likely to be read as instruction. R11. The subsequent discussion is careful and is worth keeping accessible.
-
About the Site feedback category
Reverted and then restored, after the editor supplied the source in the topic. Recording both actions; the original revert was mine and it was too quick.
-
A ten-fold dose error caught before injection
Closed under R15. The topic re-litigated a decision already answered in Meta, without new argument. The earlier answer is linked from the first post.
-
Comparing tirzepatide and semaglutide is harder than the tables suggest
Unlisted pending a response from the author about the batch and method behind the claim in the first post. If those arrive it will be relisted immediately. Under R6 this is the least destructive option available.
-
Risk-of-bias tools and the judgement they conceal
Retitled so that the title states the question. The original was a description of a feeling, which is a legitimate way to start a post and a poor way to be found in six months.
-
Payment method and the leverage it gives you, ranked
Closed under R15. The topic re-litigated a decision already answered in Meta, without new argument. The earlier answer is linked from the first post.
-
Documenting an adverse event properly
Closed under R8. Seven separate questions in one first post, five of which are answered on existing documentation pages. I have linked all five in a staff reply and opened a new topic for the two that were genuinely novel.
-
The "under review" status pill and when a moderator applies it — a second dataset
Flagged once by a member and once by a leader. The post described a research-use-only compound as equivalent to a licensed medicine after being corrected on the same point earlier in the topic. Hidden under R4. The correction remains visible above it so the thread still reads.
-
Second pass at: A history of disordered eating: proceeding carefully
Closed under R15. The topic re-litigated a decision already answered in Meta, without new argument. The earlier answer is linked from the first post.
-
Reading a denial letter as a specification for your appeal
Auto-closed after the configured interval with no reply. Nothing wrong with the topic; the platform closes quiet topics so that a two-year-old answer does not attract a new question underneath it. Anyone with a follow-up should open a new topic and link back.
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked
Moved out of the Lounge. This started as an aside and became a genuinely useful technical exchange, which is a good problem to have. It now sits where it will be found.
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic
Moved into Safety at the request of a clinician in the topic. That is the correct escalation and it does not require a moderator to agree first.
-
[2026 update] Documentation that materially improves an appeal's chances
Moved into Safety at the request of a clinician in the topic. That is the correct escalation and it does not require a moderator to agree first.
-
[2026 update] Comparing documentation quality across the directory, tabulated
Closed after the last two exchanges stopped being about the question and started being about each other. Both members have been asked to continue in Meta if they want the disagreement adjudicated. The technical content above the line stands and is worth reading.
-
Why plausible mechanism is not evidence of effect — one year on
Closed. The topic has been superseded by a maintained document that now covers the same ground with citations and a review date. The document links back here and this topic links forward. Neither is deleted.
-
[2026 update] Constipation management, with a dietitian's contribution
Flagged four times. The post reproduced a private exchange with a supplier including a personal email address. R12. The analytical content has been quoted back into the topic with the identifiers removed, which is what should have happened first.
-
An appeal that failed, and what I would do differently
Silenced for 48 hours. Six replies in one evening escalating a disagreement that another member had already de-escalated twice. Both parties were asked to stop; only one did. The other party's conduct was fine and is not recorded here.
-
Severe gastroparesis and why this class is a poor fit
Unlisted pending a response from the author about the batch and method behind the claim in the first post. If those arrive it will be relisted immediately. Under R6 this is the least destructive option available.
-
Coming back to: When "no data" is the complete and final answer
Retitled to add the missing unit. "Is 5 too much" is a different question depending on whether that is milligrams, micrograms or syringe units, and all three readings appeared in the replies.
-
Ipamorelin selectivity claims and where they came from
Closed. The topic has been superseded by a maintained document that now covers the same ground with citations and a review date. The document links back here and this topic links forward. Neither is deleted.
-
Area percent versus weight percent: the confusion that causes most arguments — what…
Retitled to remove an inaccurate compound name. The topic is about a different molecule than the title claimed, and search results were sending people to the wrong place.